Immune mediated disease | Observed | Rate ratio (95% CI) | P value |
---|---|---|---|
Addison’s disease | 25 | 2.01 (1.3-2.97) | 0.001* |
Ankylosing spondylitis | 46 | 1.64 (1.2-2.19) | 0.001* |
Autoimmune haemolytic anaemia | 16 | 1.99 (1.14-3.23) | 0.009 |
Chronic active hepatitis | 1 | 0.18 (0-0.99) | 0.08 |
Coeliac disease | 72 | 1.04 (0.82-1.32) | 0.76 |
Crohn’s disease | 159 | 1.29 (1.1-1.51) | 0.001* |
Dermatomyositis | 3 | 1.27 (0.26-3.7) | 0.93 |
Diabetes mellitus | 534 | 1.21 (1.11-1.33) | <0.001* |
Goodpasture’s syndrome | 2 | 2.31 (0.28-8.34) | 0.50 |
Hashimoto’s thyroiditis | 10 | 0.97 (0.46-1.78) | 0.96 |
Idiopathic thrombocytopenia purpura | 62 | 2.42 (1.86-3.11) | <0.001* |
Multiple sclerosis | 115 | 1.09 (0.9-1.31) | 0.41 |
Myasthenia gravis | 12 | 0.93 (0.48-1.62) | 0.91 |
Myxoedema | 1283 | 1.15 (1.09-1.22) | <0.001* |
Pemphigoid | 16 | 1.29 (0.74-2.1) | 0.38 |
Pemphigus | 3 | 1.35 (0.28-3.94) | 0.85 |
Pernicious anaemia | 96 | 1.3 (1.05-1.59) | 0.013 |
Polyarteritis nodosa | 4 | 1.79 (0.49-4.6) | 0.40 |
Polymyositis | 8 | 1.81 (0.78-3.56) | 0.15 |
Primary biliary cirrhosis | 30 | 2.21 (1.49-3.16) | <0.001* |
Psoriasis | 156 | 1.34 (1.14-1.57) | <0.001* |
Rheumatoid arthritis | 640 | 1.48 (1.36-1.6) | <0.001* |
Scleroderma | 25 | 1.84 (1.19-2.72) | 0.003 |
Sjogren’s syndrome | 39 | 1.69 (1.2-2.31) | 0.001* |
Systematic lupus erythematosus | 108 | 3.76 (3.08-4.55) | <0.001* |
Thyrotoxicosis | 202 | 1.38 (1.19-1.58) | <0.001* |
Ulcerative colitis | 198 | 1.00 (0.87-1.16) | 0.99 |